APO-GABAPENTIN
APOTEX INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-GABAPENTIN in Canada?
Yes. APO-GABAPENTIN 400MG has an active shortage reported to Health Canada (last updated August 13, 2026).
Why is APO-GABAPENTIN not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-GABAPENTIN be available again?
The estimated resolution date (August 14, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
DOM-GABAPENTIN
DOMINION PHARMACAL
Other Products
NEURONTIN
BGP PHARMA ULC
GABAPENTIN
OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.
TEVA-GABAPENTIN
TEVA CANADA LIMITED
APO-GABAPENTIN
APOTEX INC
NTP-GABAPENTIN
TEVA CANADA LIMITED
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-08-14
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02244306
Strength
400MG
Dosage Form
CAPSULE
Route
ORAL
Active Ingredient
GABAPENTIN
Tier
Unrated
Last Updated
2026-08-13
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
APO-GABAPENTIN has 3 shortage/discontinuation reports on file — this is one of them.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178